A Phase 1, Open-Label, Sequential Design Study to Evaluate the Potential Effect of Multiple Oral Doses of Extended-Release Combination of Naltrexone and Bupropion on the Pharmacokinetics of a Single Oral Dose of Metformin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2016
At a glance
- Drugs Naltrexone/bupropion (Primary) ; Metformin
- Indications Obesity
- Focus Pharmacokinetics
- Sponsors Orexigen Therapeutics; Takeda
- 27 Sep 2016 Status changed from active, no longer recruiting to completed.
- 28 Apr 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 22 Apr 2016 New trial record